SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Dr Agarwals Eye Hospital Ltd

BSE: 526783 NSE: DRAGARWQ ISIN: INE934C01018
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Dr Agarwals Eye Hospital Ltd belong to?
Dr Agarwals Eye Hospital Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Dr Agarwals Eye Hospital Ltd a good quality company?
Dr Agarwals Eye Hospital Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Dr Agarwals Eye Hospital Ltd undervalued or overvalued?
Dr Agarwals Eye Hospital Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Dr Agarwals Eye Hospital Ltd a good buy now?
Dr Agarwals Eye Hospital Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd revenue growth is 24.4% for FY-2025 , which is above its 5 year CAGR of 17.7% , indicating faster growth.
Q.2 Gross Profit margin of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Gross profit margin which is the profit after deduction of direct costs, is 27.7% for FY-2025 , which is above its 5 year median of 26.2% , indicating increasing margins.
Q.3 Operating Profit Margin of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 30.05% for FY-2025 , which is above its 5 year median of 28.88% indicating increasing margins.
Q.4 Net Profit Margin of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Net Profit Margin is 13.76% for FY-2025 , is in line with with its 5 year median of 13.76%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 27.7 26.2
Operating Profit Margin 30.05 28.88
Net Profit Margin 13.76 13.76
Q.5 Return on Asset of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Return on Asset is 8.97%, which is below its 5 year historical median of 9.63%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Return on equity is 29.8% for FY-2025 , which is below its historical median of 34.28%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Return on capital employed is 33.26% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Cash conversion cycle is -18 days, above its historical median of -26 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.65 0.71
ROE 29.8 34.28
ROCE 33.26 38.59
Cash Conversion Cycle -18 days -26 days
Q.9 Debt to Equity ratio of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Debt-to-Equity ratio is 0.46 , which is above with the industry average of 0.22 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd Debt to cash flow from operations is 1.02 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Dr Agarwals Eye Hospital Ltd?
Promoters hold 72.67% of the Dr Agarwals Eye Hospital Ltd, with 29.26% of their stake pledged, indicating high pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Dr Agarwals Eye Hospital Ltd vs industry peers?
Dr Agarwals Eye Hospital Ltd revenue CAGR is 17.68% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 397.2 144
Gross Profit 110 8.2
Operating Profit 119 8.4
Net Profit 55 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.65 0.73
ROE 29.8 13.88
ROCE 33.26 17.77
Cash Conversion Cycle (days) -18.31 2

Valuation & price assessment

Q.1 Stock return of Dr Agarwals Eye Hospital Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 39.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 39.8% 72.8% 61.5% 11.1%
Q.3 Valuation ratios of Dr Agarwals Eye Hospital Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 33.6 30.70 79.71
Price to Book 7.07 7.06 3.54
Price to Sales 5.21 4.18 4.37
EV to EBITDA 16.46 14.74 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Park Medi World
9. Metropolis Health.
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×